Download PDF
Semin Neurol 2023; 43(06): 867-888
DOI: 10.1055/s-0043-1776765
Review Article

Brain Tumor Imaging: Review of Conventional and Advanced Techniques

Andrew Campion
1   Department of Radiology (Neuroradiology), Stanford University, Stanford, California
,
Michael Iv
1   Department of Radiology (Neuroradiology), Stanford University, Stanford, California
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Approaches to central nervous system (CNS) tumor classification and evaluation have undergone multiple iterations over the past few decades, in large part due to our growing understanding of the influence of genetics on tumor behavior and our refinement of brain tumor imaging techniques. Computed tomography and magnetic resonance imaging (MRI) both play a critical role in the diagnosis and monitoring of brain tumors, although MRI has become especially important due to its superior soft tissue resolution. The purpose of this article will be to briefly review the fundamentals of conventional and advanced techniques used in brain tumor imaging. We will also highlight the applications of these imaging tools in the context of commonly encountered tumors based on the most recently updated 2021 World Health Organization (WHO) classification of CNS tumors framework.

Keywords

brain tumors - MRI - perfusion - neuro-oncology


Publication History

Article published online:
14 November 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Louis DN, Ohgaki H, Wiestler OD. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114 (02) 97-109
    CrossrefPubMedGoogle Scholar
  • 2 Johnson DR, Giannini C, Vaubel RA. et al. A radiologist's guide to the 2021 who central nervous system tumor classification: part i—key concepts and the spectrum of diffuse gliomas. Radiology 2022; 304 (03) 494-508
    CrossrefPubMedGoogle Scholar
  • 3 Louis DN, Perry A, Reifenberger G. et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131 (06) 803-820
    CrossrefPubMedGoogle Scholar
  • 4 Brat DJ, Verhaak RG, Aldape KD. et al; Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 2015; 372 (26) 2481-2498
    CrossrefPubMedGoogle Scholar
  • 5 Louis DN, Perry A, Wesseling P. et al. The 2021 who classification of tumors of the central nervous system: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
    CrossrefPubMedGoogle Scholar
  • 6 Gao H, Jiang X. Progress on the diagnosis and evaluation of brain tumors. Cancer Imaging 2013; 13 (04) 466-481
    CrossrefPubMedGoogle Scholar
  • 7 Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 2003; 33 (02) 148-162
    CrossrefPubMedGoogle Scholar
  • 8 Mabray MC, Barajas Jr RF, Cha S. Modern brain tumor imaging. Brain Tumor Res Treat 2015; 3 (01) 8-23
    CrossrefPubMedGoogle Scholar
  • 9 Li AY, Iv M. Conventional and advanced imaging techniques in post-treatment glioma imaging. Front Radiol 2022; 2: 883293
    CrossrefPubMedGoogle Scholar
  • 10 Iv M, Yoon BC, Heit JJ, Fischbein N, Wintermark M. Current clinical state of advanced magnetic resonance imaging for brain tumor diagnosis and follow up. Semin Roentgenol 2018; 53 (01) 45-61
    CrossrefPubMedGoogle Scholar
  • 11 Ellingson BM, Malkin MG, Rand SD. et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010; 31 (03) 538-548
    CrossrefPubMedGoogle Scholar
  • 12 Sugahara T, Korogi Y, Kochi M. et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999; 9 (01) 53-60
    CrossrefPubMedGoogle Scholar
  • 13 Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002; 224 (01) 177-183
    CrossrefPubMedGoogle Scholar
  • 14 Al Sayyari A, Buckley R, McHenery C, Pannek K, Coulthard A, Rose S. Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy. AJNR Am J Neuroradiol 2010; 31 (06) 1049-1054
    CrossrefPubMedGoogle Scholar
  • 15 Lee WJ, Choi SH, Park CK. et al. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas. Acad Radiol 2012; 19 (11) 1353-1361
    CrossrefPubMedGoogle Scholar
  • 16 Svolos P, Kousi E, Kapsalaki E. et al. The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives. Cancer Imaging 2014; 14 (01) 20
    CrossrefPubMedGoogle Scholar
  • 17 Lee SJ, Kim JH, Kim YM. et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol 2001; 2 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 18 Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?. AJNR Am J Neuroradiol 2009; 30 (04) 681-688
    CrossrefPubMedGoogle Scholar
  • 19 Danchaivijitr N, Waldman AD, Tozer DJ. et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?. Radiology 2008; 247 (01) 170-178
    CrossrefPubMedGoogle Scholar
  • 20 Shiroishi MS, Habibi M, Rajderkar D. et al. Perfusion and permeability MR imaging of gliomas. Technol Cancer Res Treat 2011; 10 (01) 59-71
    CrossrefPubMedGoogle Scholar
  • 21 Hu LS, Baxter LC, Smith KA. et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009; 30 (03) 552-558
    CrossrefPubMedGoogle Scholar
  • 22 Vidyasagar R, Abernethy L, Pizer B, Avula S, Parkes LM. Quantitative measurement of blood flow in paediatric brain tumours-a comparative study of dynamic susceptibility contrast and multi time-point arterial spin labelled MRI. Br J Radiol 2016; 89 (1062): 20150624
    CrossrefPubMedGoogle Scholar
  • 23 White CM, Pope WB, Zaw T. et al. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors: regional and voxel-wise comparisons of blood flow measurements. J Neuroimaging 2014; 24 (01) 23-30
    CrossrefPubMedGoogle Scholar
  • 24 Roberts HC, Roberts TPL, Bollen AW, Ley S, Brasch RC, Dillon WP. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001; 8 (05) 384-391
    CrossrefPubMedGoogle Scholar
  • 25 Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21 (05) 891-899
    PubMedGoogle Scholar
  • 26 Brandão LA, Castillo M. Adult brain tumors: clinical applications of magnetic resonance spectroscopy. Magn Reson Imaging Clin N Am 2016; 24 (04) 781-809
    CrossrefPubMedGoogle Scholar
  • 27 Saraswathy S, Crawford FW, Lamborn KR. et al. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol 2009; 91 (01) 69-81
    CrossrefPubMedGoogle Scholar
  • 28 Ishimaru H, Morikawa M, Iwanaga S, Kaminogo M, Ochi M, Hayashi K. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol 2001; 11 (09) 1784-1791
    CrossrefPubMedGoogle Scholar
  • 29 Verma A, Kumar I, Verma N, Aggarwal P, Ojha R. Magnetic resonance spectroscopy - revisiting the biochemical and molecular milieu of brain tumors. BBA Clin 2016; 5: 170-178
    CrossrefPubMedGoogle Scholar
  • 30 Law M, Yang S, Wang H. et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24 (10) 1989-1998
    PubMedGoogle Scholar
  • 31 Chuang MT, Liu YS, Tsai YS, Chen YC, Wang CK. Differentiating radiation-induced necrosis from recurrent brain tumor using MR perfusion and spectroscopy: a meta-analysis. PLoS ONE 2016; 11 (01) e0141438
    CrossrefPubMedGoogle Scholar
  • 32 Eckel-Passow JE, Lachance DH, Molinaro AM. et al. Glioma groups based on 1p/19q, idh, and tert promoter mutations in tumors. N Engl J Med 2015; 372 (26) 2499-2508
    CrossrefPubMedGoogle Scholar
  • 33 Osborn AG, Hedlund GL, Salzman KL. Osborn's Brain: Imaging, Pathology, and Anatomy. 2nd ed.. Elsevier; 2018
    Google Scholar
  • 34 Deguchi S, Oishi T, Mitsuya K. et al. Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas. Sci Rep 2020; 10 (01) 10113
    CrossrefPubMedGoogle Scholar
  • 35 Broen MPG, Smits M, Wijnenga MMJ. et al. The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study. Neuro-oncol 2018; 20 (10) 1393-1399
    CrossrefPubMedGoogle Scholar
  • 36 Park SI, Suh CH, Guenette JP, Huang RY, Kim HS. The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. Eur Radiol 2021; 31 (07) 5289-5299
    CrossrefPubMedGoogle Scholar
  • 37 Jain R, Johnson DR, Patel SH. et al. “Real world” use of a highly reliable imaging sign: “T2-FLAIR mismatch” for identification of IDH mutant astrocytomas. Neuro-oncol 2020; 22 (07) 936-943
    CrossrefPubMedGoogle Scholar
  • 38 Le D, Trinh K, Das N, Kuo AH. T2-fluid attenuated inversion recovery mismatch in tumefactive multiple sclerosis. BJR Case Rep 2023; 9 (01) 20220138
    PubMedGoogle Scholar
  • 39 Smits M. Imaging of oligodendroglioma. Br J Radiol 2016; 89 (1060): 20150857
    CrossrefPubMedGoogle Scholar
  • 40 Murakami R, Sugahara T, Nakamura H. et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007; 243 (02) 493-499
    CrossrefPubMedGoogle Scholar
  • 41 Zulfiqar M, Yousem DM, Lai H. ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?–a meta-analysis. AJR Am J Roentgenol 2013; 200 (03) 624-629
    CrossrefPubMedGoogle Scholar
  • 42 Yang X, Xing Z, She D. et al. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging. BMC Med Imaging 2022; 22 (01) 105
    CrossrefPubMedGoogle Scholar
  • 43 Hirai T, Murakami R, Nakamura H. et al. Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol 2008; 29 (08) 1505-1510
    CrossrefPubMedGoogle Scholar
  • 44 Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging 2018; 9 (06) 1057-1075
    CrossrefPubMedGoogle Scholar
  • 45 Young RJ, Gupta A, Shah AD. et al. Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology 2011; 76 (22) 1918-1924
    CrossrefPubMedGoogle Scholar
  • 46 Reuter G, Moïse M, Roll W. et al. Conventional and advanced imaging throughout the cycle of care of gliomas. Neurosurg Rev 2021; 44 (05) 2493-2509
    CrossrefPubMedGoogle Scholar
  • 47 Asao C, Korogi Y, Kitajima M. et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 2005; 26 (06) 1455-1460
    PubMedGoogle Scholar
  • 48 Gupta A, Young RJ, Karimi S. et al. Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma. AJNR Am J Neuroradiol 2011; 32 (07) 1301-1306
    CrossrefPubMedGoogle Scholar
  • 49 Iv M, Liu X, Lavezo J. et al. Perfusion MRI-based fractional tumor burden differentiates between tumor and treatment effect in recurrent glioblastomas and informs clinical decision-making. AJNR Am J Neuroradiol 2019; 40 (10) 1649-1657
    PubMedGoogle Scholar
  • 50 Gasparetto EL, Pawlak MA, Patel SH. et al. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction. Radiology 2009; 250 (03) 887-896
    CrossrefPubMedGoogle Scholar
  • 51 Horská A, Barker PB. Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am 2010; 20 (03) 293-310
    CrossrefPubMedGoogle Scholar
  • 52 Weinberg BD, Kuruva M, Shim H, Mullins ME. Clinical applications of magnetic resonance spectroscopy in brain tumors. Radiol Clin North Am 2021; 59 (03) 349-362
    CrossrefPubMedGoogle Scholar
  • 53 Koelsche C, Wöhrer A, Jeibmann A. et al. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol 2013; 125 (06) 891-900
    CrossrefPubMedGoogle Scholar
  • 54 Bale TA. FGFR- gene family alterations in low-grade neuroepithelial tumors. Acta Neuropathol Commun 2020; 8 (01) 21
    CrossrefPubMedGoogle Scholar
  • 55 Vaz A, Cavalcanti MS, da Silva Junior EB, Ramina R, de Almeida Teixeira BC. Uncommon glioneuronal tumors: a radiologic and pathologic synopsis. AJNR Am J Neuroradiol 2022; 43 (08) 1080-1089
    CrossrefPubMedGoogle Scholar
  • 56 Krauze AV. Glioneuronal tumors: insights into a rare tumor entity. In: Debinski W. eds. Gliomas. Winston Salem, NC. Exon Publications; 2021: 211-228
    Google Scholar
  • 57 Takahashi A, Hong SC, Seo DW, Hong SB, Lee M, Suh YL. Frequent association of cortical dysplasia in dysembryoplastic neuroepithelial tumor treated by epilepsy surgery. Surg Neurol 2005; 64 (05) 419-427
    CrossrefPubMedGoogle Scholar
  • 58 Shin JH, Lee HK, Khang SK. et al. Neuronal tumors of the central nervous system: radiologic findings and pathologic correlation. Radiographics 2002; 22 (05) 1177-1189
    CrossrefPubMedGoogle Scholar
  • 59 Klisch J, Juengling F, Spreer J. et al. Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol 2001; 22 (05) 824-830
    PubMedGoogle Scholar
  • 60 Nunes RH, Hsu CC, da Rocha AJ. et al. Multinodular and vacuolating neuronal tumor of the cerebrum: a new “leave me alone” lesion with a characteristic imaging pattern. AJNR Am J Neuroradiol 2017; 38 (10) 1899-1904
    CrossrefPubMedGoogle Scholar
  • 61 Smith AB, Smirniotopoulos JG, Horkanyne-Szakaly I. From the radiologic pathology archives: intraventricular neoplasms: radiologic-pathologic correlation. Radiographics 2013; 33 (01) 21-43
    CrossrefPubMedGoogle Scholar
  • 62 Tamrazi B, Shiroishi MS, Liu CSJ. Advanced imaging of intracranial meningiomas. Neurosurg Clin N Am 2016; 27 (02) 137-143
    CrossrefPubMedGoogle Scholar
  • 63 Maas SLN, Stichel D, Hielscher T. et al; German Consortium on Aggressive Meningiomas (KAM). Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 2021; 39 (34) 3839-3852
    CrossrefPubMedGoogle Scholar
  • 64 Backer-Grøndahl T, Moen BH, Torp SH. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 2012; 5 (03) 231-242
    PubMedGoogle Scholar
  • 65 Behling F, Hempel JM, Schittenhelm J. Brain invasion in meningioma—a prognostic potential worth exploring. Cancers (Basel) 2021; 13 (13) 3259
    CrossrefPubMedGoogle Scholar
  • 66 Baumgarten P, Gessler F, Schittenhelm J. et al. Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 2016; 132 (03) 479-481
    CrossrefPubMedGoogle Scholar
  • 67 Takeguchi T, Miki H, Shimizu T. et al. Evaluation of the tumor-brain interface of intracranial meningiomas on MR imaging including FLAIR images. Magn Reson Med Sci 2003; 2 (04) 165-169
    CrossrefPubMedGoogle Scholar
  • 68 Sotoudeh H, Yazdi HR. A review on dural tail sign. World J Radiol 2010; 2 (05) 188-192
    CrossrefPubMedGoogle Scholar
  • 69 Spille DC, Sporns PB, Heß K, Stummer W, Brokinkel B. Prediction of high-grade histology and recurrence in meningiomas using routine preoperative magnetic resonance imaging: a systematic review. World Neurosurg 2019; 128: 174-181
    CrossrefPubMedGoogle Scholar
  • 70 Bano S, Waraich MM, Khan MA, Buzdar SA, Manzur S. Diagnostic value of apparent diffusion coefficient for the accurate assessment and differentiation of intracranial meningiomas. Acta Radiol Short Rep 2013; 2 (07) 2047981613512484
    PubMedGoogle Scholar
  • 71 Filippi CG, Edgar MA, Uluğ AM, Prowda JC, Heier LA, Zimmerman RD. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001; 22 (01) 65-72
    PubMedGoogle Scholar
  • 72 Mayercik V, Ma M, Holdsworth S, Heit J, Iv M. Arterial spin-labeling MRI identifies hypervascular meningiomas. AJR Am J Roentgenol 2019; 213 (05) 1124-1128
    CrossrefPubMedGoogle Scholar
  • 73 Kremer S, Grand S, Rémy C. et al. Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 2004; 46 (08) 642-648
    CrossrefPubMedGoogle Scholar
  • 74 Smith AB, Horkanyne-Szakaly I, Schroeder JW, Rushing EJ. From the radiologic pathology archives: mass lesions of the dura: beyond meningioma-radiologic-pathologic correlation. Radiographics 2014; 34 (02) 295-312
    CrossrefPubMedGoogle Scholar
  • 75 Alaggio R, Amador C, Anagnostopoulos I. et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 2022; 36 (07) 1720-1748
    CrossrefPubMedGoogle Scholar
  • 76 Pons-Escoda A, Naval-Baudin P, Velasco R, Vidal N, Majós C. Imaging of lymphomas involving the CNS: an update-review of the full spectrum of disease with an emphasis on the world health organization classifications of CNS tumors 2021 and hematolymphoid tumors 2022. AJNR Am J Neuroradiol 2023; 44 (04) 358-366
    CrossrefPubMedGoogle Scholar
  • 77 Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011; 32 (06) 984-992
    CrossrefPubMedGoogle Scholar
  • 78 Sakata A, Okada T, Yamamoto A. et al. Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?. Radiol Oncol 2015; 49 (02) 128-134
    CrossrefPubMedGoogle Scholar
  • 79 Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011; 32 (06) 1004-1010
    CrossrefPubMedGoogle Scholar
  • 80 Lee MD, Baird GL, Bell LC, Quarles CC, Boxerman JL. Utility of percentage signal recovery and baseline signal in DSC-MRI optimized for relative CBV measurement for differentiating glioblastoma, lymphoma, metastasis, and meningioma. AJNR Am J Neuroradiol 2019; 40 (09) 1445-1450
    PubMedGoogle Scholar
  • 81 Mahale P, Shiels MS, Lynch CF, Engels EA. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. Am J Transplant 2018; 18 (02) 453-461
    CrossrefPubMedGoogle Scholar
  • 82 Kaulen LD, Karschnia P, Dietrich J, Baehring JM. Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysis. J Neurooncol 2020; 149 (01) 153-159
    CrossrefPubMedGoogle Scholar
  • 83 Suh CH, Kim HS, Lee SS. et al. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging. Radiology 2014; 272 (02) 504-513
    CrossrefPubMedGoogle Scholar
  • 84 Chang L, Cornford ME, Chiang FL, Ernst TM, Sun NC, Miller BL. Radiologic-pathologic correlation. Cerebral toxoplasmosis and lymphoma in AIDS. AJNR Am J Neuroradiol 1995; 16 (08) 1653-1663
    PubMedGoogle Scholar
  • 85 Ernst TM, Chang L, Witt MD. et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology 1998; 208 (03) 663-669
    CrossrefPubMedGoogle Scholar
  • 86 Wang S, Kim S, Chawla S. et al. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011; 32 (03) 507-514
    CrossrefPubMedGoogle Scholar
  • 87 Bobillo S, Khwaja J, Ferreri AJM, Cwynarski K. Prevention and management of secondary central nervous system lymphoma. Haematologica 2023; 108 (03) 673-689
    CrossrefPubMedGoogle Scholar
  • 88 Ferreri AJM, Doorduijn JK, Re A. et al; International Extranodal Lymphoma Study Group (IELSG). MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. Lancet Haematol 2021; 8 (02) e110-e121
    CrossrefPubMedGoogle Scholar
  • 89 Fink KR, Fink JR. Imaging of brain metastases. Surg Neurol Int 2013; 4 (5, suppl 4): S209-S219
    CrossrefPubMedGoogle Scholar
  • 90 Fordham AJ, Hacherl CC, Patel N. et al. Differentiating glioblastomas from solitary brain metastases: an update on the current literature of advanced imaging modalities. Cancers (Basel) 2021; 13 (12) 2960
    CrossrefPubMedGoogle Scholar
  • 91 Server A, Orheim TED, Graff BA, Josefsen R, Kumar T, Nakstad PH. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 2011; 53 (05) 319-330
    CrossrefPubMedGoogle Scholar
  • 92 Blasel S, Jurcoane A, Franz K, Morawe G, Pellikan S, Hattingen E. Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir (Wien) 2010; 152 (11) 1893-1899
    CrossrefPubMedGoogle Scholar
  • 93 Cha S, Lupo JM, Chen MH. et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007; 28 (06) 1078-1084
    CrossrefPubMedGoogle Scholar
  • 94 Suh CH, Kim HS, Jung SC, Kim SJ. Diffusion-weighted imaging and diffusion tensor imaging for differentiating high-grade glioma from solitary brain metastasis: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2018; 39 (07) 1208-1214
    CrossrefPubMedGoogle Scholar
  • 95 Lee D, Riestenberg RA, Haskell-Mendoza A, Bloch O. Brain metastasis recurrence versus radiation necrosis. Neurosurg Clin N Am 2020; 31 (04) 575-587
    CrossrefPubMedGoogle Scholar
  • 96 Mitsuya K, Nakasu Y, Horiguchi S. et al. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 2010; 99 (01) 81-88
    CrossrefPubMedGoogle Scholar
  • 97 Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001; 14 (06) 339-349
    CrossrefPubMedGoogle Scholar
  • 98 Lyndon D, Lansley JA, Evanson J, Krishnan AS. Dural masses: meningiomas and their mimics. Insights Imaging 2019; 10 (01) 11
    CrossrefPubMedGoogle Scholar
  • 99 Singh SK, Agris JM, Leeds NE, Ginsberg LE. Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology 2000; 217 (01) 50-53
    CrossrefPubMedGoogle Scholar